Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial

Purpose: To investigate the effect of omega-3 polyunsaturated fatty acid supplement on qualitative and quantitative subjective (ocular surface disease index [OSDI]) and objective (Schirmer's test, tear break up time [TBUT], and tear osmolarity) dry eye indices after cataract surgery. Methods: I...

Full description

Bibliographic Details
Main Authors: Mehrdad Mohammadpour, Shima Mehrabi, Narges Hassanpoor, Reza Mirshahi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-03-01
Series:Journal of Current Ophthalmology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2452232516300634
id doaj-2bcfe607634340ed95dde1958d0946ec
record_format Article
spelling doaj-2bcfe607634340ed95dde1958d0946ec2021-04-02T14:01:39ZengWolters Kluwer Medknow PublicationsJournal of Current Ophthalmology2452-23252017-03-01291333810.1016/j.joco.2016.05.006Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trialMehrdad MohammadpourShima MehrabiNarges HassanpoorReza MirshahiPurpose: To investigate the effect of omega-3 polyunsaturated fatty acid supplement on qualitative and quantitative subjective (ocular surface disease index [OSDI]) and objective (Schirmer's test, tear break up time [TBUT], and tear osmolarity) dry eye indices after cataract surgery. Methods: In this randomized clinical study, 61 eyes of 48 patients complaining of new onset dry eye symptoms after phacoemulsification were enrolled. Subjects were randomly allocated into two groups using urn randomization. Controls received conventional treatment. The treatment group received omega-3 dietary supplement in addition to conventional therapy. Results: There was no significant difference between the control and treatment groups in pre-treatment indices of Schirmer (3.50 ± 3.13 and 2.96 ± 3.39, respectively, P = 0.582), TBUT (6.67 ± 1.36 and 4.87 ± 2.22, respectively, P = 0.687), osmolarity (316.66 ± 8.50 and 315.4 ± 17.06, respectively, P = 0.906), and OSDI (32.99 ± 19.03 and 35.32 ± 18.99, respectively, P = 0.635). Mean pre-treatment OSDI in the control group was 32.99 ± 19.03, which improved significantly after treatment to 25.43 ± 14.49 (P = 0.003). The mean pre-treatment OSDI in the treatment group was 35.32 ± 18.99 (range: 7.5–77.77), which improved significantly after treatment to 16.31 ± 13.72 (range: 2.77–47.22) (P < 0.001). OSDI improvement was significantly higher in the treatment group than the control group (P = 0.026). TBUT improved in both the control and treatment groups after treatment (P < 0.001). However, TBUT was affected significantly more in the treatment group compared with the control group (P = 0.038). Mean tear film osmolarity in the control group was 316.67 ± 8.50 (range: 308–325), which improved insignificantly after treatment to 311.33 ± 6.35 (range: 304–315) (P = 0.157). Mean pre-treatment tear film osmolarity in the treatment group was 315.40 ± 17.06 (range: 279–340), which improved significantly after treatment to 296.90 ± 14.39 (range: 260–310) (P < 0.001). Also, post-treatment Schirmer results between the two groups were not statistically significant (P = 0.155). Conclusion: Omega-3 dietary supplements have an additive effect on tear film indices of patients with dry eye syndrome after phacoemulsification.http://www.sciencedirect.com/science/article/pii/S2452232516300634Polyunsaturated fatty acidsOmega-3Dry eyeCataract surgery
collection DOAJ
language English
format Article
sources DOAJ
author Mehrdad Mohammadpour
Shima Mehrabi
Narges Hassanpoor
Reza Mirshahi
spellingShingle Mehrdad Mohammadpour
Shima Mehrabi
Narges Hassanpoor
Reza Mirshahi
Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial
Journal of Current Ophthalmology
Polyunsaturated fatty acids
Omega-3
Dry eye
Cataract surgery
author_facet Mehrdad Mohammadpour
Shima Mehrabi
Narges Hassanpoor
Reza Mirshahi
author_sort Mehrdad Mohammadpour
title Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial
title_short Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial
title_full Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial
title_fullStr Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial
title_full_unstemmed Effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: A randomized clinical trial
title_sort effects of adjuvant omega-3 fatty acid supplementation on dry eye syndrome following cataract surgery: a randomized clinical trial
publisher Wolters Kluwer Medknow Publications
series Journal of Current Ophthalmology
issn 2452-2325
publishDate 2017-03-01
description Purpose: To investigate the effect of omega-3 polyunsaturated fatty acid supplement on qualitative and quantitative subjective (ocular surface disease index [OSDI]) and objective (Schirmer's test, tear break up time [TBUT], and tear osmolarity) dry eye indices after cataract surgery. Methods: In this randomized clinical study, 61 eyes of 48 patients complaining of new onset dry eye symptoms after phacoemulsification were enrolled. Subjects were randomly allocated into two groups using urn randomization. Controls received conventional treatment. The treatment group received omega-3 dietary supplement in addition to conventional therapy. Results: There was no significant difference between the control and treatment groups in pre-treatment indices of Schirmer (3.50 ± 3.13 and 2.96 ± 3.39, respectively, P = 0.582), TBUT (6.67 ± 1.36 and 4.87 ± 2.22, respectively, P = 0.687), osmolarity (316.66 ± 8.50 and 315.4 ± 17.06, respectively, P = 0.906), and OSDI (32.99 ± 19.03 and 35.32 ± 18.99, respectively, P = 0.635). Mean pre-treatment OSDI in the control group was 32.99 ± 19.03, which improved significantly after treatment to 25.43 ± 14.49 (P = 0.003). The mean pre-treatment OSDI in the treatment group was 35.32 ± 18.99 (range: 7.5–77.77), which improved significantly after treatment to 16.31 ± 13.72 (range: 2.77–47.22) (P < 0.001). OSDI improvement was significantly higher in the treatment group than the control group (P = 0.026). TBUT improved in both the control and treatment groups after treatment (P < 0.001). However, TBUT was affected significantly more in the treatment group compared with the control group (P = 0.038). Mean tear film osmolarity in the control group was 316.67 ± 8.50 (range: 308–325), which improved insignificantly after treatment to 311.33 ± 6.35 (range: 304–315) (P = 0.157). Mean pre-treatment tear film osmolarity in the treatment group was 315.40 ± 17.06 (range: 279–340), which improved significantly after treatment to 296.90 ± 14.39 (range: 260–310) (P < 0.001). Also, post-treatment Schirmer results between the two groups were not statistically significant (P = 0.155). Conclusion: Omega-3 dietary supplements have an additive effect on tear film indices of patients with dry eye syndrome after phacoemulsification.
topic Polyunsaturated fatty acids
Omega-3
Dry eye
Cataract surgery
url http://www.sciencedirect.com/science/article/pii/S2452232516300634
work_keys_str_mv AT mehrdadmohammadpour effectsofadjuvantomega3fattyacidsupplementationondryeyesyndromefollowingcataractsurgeryarandomizedclinicaltrial
AT shimamehrabi effectsofadjuvantomega3fattyacidsupplementationondryeyesyndromefollowingcataractsurgeryarandomizedclinicaltrial
AT nargeshassanpoor effectsofadjuvantomega3fattyacidsupplementationondryeyesyndromefollowingcataractsurgeryarandomizedclinicaltrial
AT rezamirshahi effectsofadjuvantomega3fattyacidsupplementationondryeyesyndromefollowingcataractsurgeryarandomizedclinicaltrial
_version_ 1721563256206655488